Tideglusib, a chemical inhibitor of GSK3β, attenuates hypoxic-ischemic brain injury in neonatal mice
Haitao Wang(China South Industries Group (China)), Zhong‐Ping Feng(University of Toronto), Hong‐Shuo Sun(University of Toronto), Ahmed Abussaud(University of Toronto), Xiaoyan Fang(University of Toronto), Kuipo Yan(University of Toronto), Sammen Huang(University of Toronto), Ana Martı́nez(Consejo Superior de Investigaciones Científicas)
Cited by 55
Related Papers
Synapse formation between central neurons requires postsynaptic expression of the MEN1 tumor suppressor gene.
|PubMed|2001|469
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
cAMP Response Element-Binding Protein (CREB): A Possible Signaling Molecule Link in the Pathophysiology of Schizophrenia
|Frontiers in Molecular Neuroscience|2018|442
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348